z-logo
open-access-imgOpen Access
C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging
Author(s) -
Tjakko J. van Ham,
Karen L. Thijssen,
Rainer Breitling,
Robert M.W. Hofstra,
Ronald H.A. Plasterk,
Ellen A. A. Nollen
Publication year - 2008
Publication title -
plos genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.587
H-Index - 233
eISSN - 1553-7404
pISSN - 1553-7390
DOI - 10.1371/journal.pgen.1000027
Subject(s) - biology , alpha synuclein , endomembrane system , caenorhabditis elegans , mechanism (biology) , gene , rna interference , genetics , inclusion bodies , golgi apparatus , microbiology and biotechnology , disease , parkinson's disease , rna , endoplasmic reticulum , pathology , medicine , philosophy , epistemology , escherichia coli
Inclusions in the brain containing α-synuclein are the pathological hallmark of Parkinson's disease, but how these inclusions are formed and how this links to disease is poorly understood. We have developed a C. elegans model that makes it possible to monitor, in living animals, the formation of α-synuclein inclusions. In worms of old age, inclusions contain aggregated α- synuclein, resembling a critical pathological feature. We used genome-wide RNA interference to identify processes involved in inclusion formation, and identified 80 genes that, when knocked down, resulted in a premature increase in the number of inclusions. Quality control and vesicle-trafficking genes expressed in the ER/Golgi complex and vesicular compartments were overrepresented, indicating a specific role for these processes in α-synuclein inclusion formation. Suppressors include aging-associated genes, such as sir-2.1/SIRT1 and lagr-1/LASS2. Altogether, our data suggest a link between α-synuclein inclusion formation and cellular aging, likely through an endomembrane-related mechanism. The processes and genes identified here present a framework for further study of the disease mechanism and provide candidate susceptibility genes and drug targets for Parkinson's disease and other α-synuclein related disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom